Archimeded granted Pharmalink exclusive worldwide rights to use Archimedes' Tarqit drug delivery technology for use with Nefecon to treat IgA nephropathy

Archimedes Inc.

U.S. / Other

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Pharmalink AB

Sweden / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced